Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA; Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, USA.
Lancet. 2018 May 12;391(10133):1908-1915. doi: 10.1016/S0140-6736(17)33050-7. Epub 2018 Mar 1.
Cholera remains a persistent health problem in sub-Saharan Africa and worldwide. Cholera can be controlled through appropriate water and sanitation, or by oral cholera vaccination, which provides transient (∼3 years) protection, although vaccine supplies remain scarce. We aimed to map cholera burden in sub-Saharan Africa and assess how geographical targeting could lead to more efficient interventions.
We combined information on cholera incidence in sub-Saharan Africa (excluding Djibouti and Eritrea) from 2010 to 2016 from datasets from WHO, Médecins Sans Frontières, ProMED, ReliefWeb, ministries of health, and the scientific literature. We divided the study region into 20 km × 20 km grid cells and modelled annual cholera incidence in each grid cell assuming a Poisson process adjusted for covariates and spatially correlated random effects. We combined these findings with data on population distribution to estimate the number of people living in areas of high cholera incidence (>1 case per 1000 people per year). We further estimated the reduction in cholera incidence that could be achieved by targeting cholera prevention and control interventions at areas of high cholera incidence.
We included 279 datasets covering 2283 locations in our analyses. In sub-Saharan Africa (excluding Djibouti and Eritrea), a mean of 141 918 cholera cases (95% credible interval [CrI] 141 538-146 505) were reported per year. 4·0% (95% CrI 1·7-16·8) of districts, home to 87·2 million people (95% CrI 60·3 million to 118·9 million), have high cholera incidence. By focusing on the highest incidence districts first, effective targeted interventions could eliminate 50% of the region's cholera by covering 35·3 million people (95% CrI 26·3 million to 62·0 million), which is less than 4% of the total population.
Although cholera occurs throughout sub-Saharan Africa, its highest incidence is concentrated in a small proportion of the continent. Prioritising high-risk areas could substantially increase the efficiency of cholera control programmes.
The Bill & Melinda Gates Foundation.
霍乱仍然是撒哈拉以南非洲和全球持续存在的健康问题。通过适当的水和卫生设施,或通过口服霍乱疫苗可以控制霍乱,疫苗可提供短暂(约 3 年)的保护,尽管疫苗供应仍然稀缺。我们旨在绘制撒哈拉以南非洲的霍乱负担图,并评估地理目标定位如何能带来更有效的干预措施。
我们结合了来自世卫组织、无国界医生组织、ProMED、ReliefWeb、卫生部和科学文献的 2010 年至 2016 年期间撒哈拉以南非洲(不包括吉布提和厄立特里亚)的霍乱发病率数据。我们将研究区域划分为 20km×20km 的网格单元,并假设泊松过程调整了协变量和空间相关随机效应,对每个网格单元的年度霍乱发病率进行建模。我们将这些发现与人口分布数据结合起来,以估计生活在高霍乱发病率地区(每年每 1000 人中有 1 例以上)的人数。我们还进一步估计了通过针对高霍乱发病率地区的霍乱预防和控制干预措施,可使霍乱发病率降低多少。
我们的分析包括 279 个数据集,涵盖 2283 个地点。在撒哈拉以南非洲(不包括吉布提和厄立特里亚),每年报告的霍乱病例数平均为 141918 例(95%可信区间 [CrI] 141538-146505)。4.0%(95% CrI 1.7-16.8)的地区,有 8720 万人(95% CrI 6030 万人至 11890 万人)居住在霍乱发病率高的地区。通过首先关注发病率最高的地区,有效的针对性干预措施可以覆盖 3530 万人(95% CrI 2630 万人至 6200 万人),从而消除该地区 50%的霍乱病例,这不到总人口的 4%。
尽管霍乱在整个撒哈拉以南非洲都有发生,但它的最高发病率集中在该大陆的一小部分地区。优先考虑高风险地区可以大大提高霍乱控制计划的效率。
比尔及梅琳达·盖茨基金会。